Indian generic drugmaker settles lawsuit with Leo Pharma
Glenmark, an Indian developer of generic medicines, has agreed to a confidential settlement with Leo Pharma concerning a generic version of the Danish firm’s foam treatment for plaque psoriasis.
by ulrich quistgaard, translated by daniel pedersen
Leo Pharma’s lawsuit against Indian generic drugmaker Glenmark has concluded in a settlement, Leo Pharma informs MedWatch by email.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Lundbeck preps for war against generic drugmakers in US
For subscribers
Novo Nordisk sues Teva over generic drug development
For subscribers
.jpg&w=384&q=75)
